搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Thermococcus gammatolerans 50S ribosomal protein L31e (rpl31e) CSB-YP510852TMP
CSB-EP510852TMP
CSB-BP510852TMP
CSB-MP510852TMP
CSB-EP510852TMP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium extorquens Ribosomal RNA small subunit methyltransferase H (rsmH) CSB-YP510853MSZ
CSB-EP510853MSZ
CSB-BP510853MSZ
CSB-MP510853MSZ
CSB-EP510853MSZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Edwardsiella ictaluri Glycerol-3-phosphate acyltransferase (plsB), partial CSB-YP510854EJO
CSB-EP510854EJO
CSB-BP510854EJO
CSB-MP510854EJO
CSB-EP510854EJO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Edwardsiella ictaluri Proline--tRNA ligase (proS), partial CSB-YP510855EJO
CSB-EP510855EJO
CSB-BP510855EJO
CSB-MP510855EJO
CSB-EP510855EJO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Edwardsiella ictaluri 2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate synthase (menD), partial CSB-YP510856EJO
CSB-EP510856EJO
CSB-BP510856EJO
CSB-MP510856EJO
CSB-EP510856EJO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Edwardsiella ictaluri Dihydrodipicolinate reductase (dapB) CSB-YP510857EJO
CSB-EP510857EJO
CSB-BP510857EJO
CSB-MP510857EJO
CSB-EP510857EJO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Edwardsiella ictaluri Ribonuclease HII (rnhB) CSB-YP510858EJO
CSB-EP510858EJO
CSB-BP510858EJO
CSB-MP510858EJO
CSB-EP510858EJO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Edwardsiella ictaluri Glutamyl-tRNA reductase (hemA) CSB-YP510859EJO
CSB-EP510859EJO
CSB-BP510859EJO
CSB-MP510859EJO
CSB-EP510859EJO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Edwardsiella ictaluri Phenylalanine--tRNA ligase alpha subunit (pheS) CSB-YP510860EJO
CSB-EP510860EJO
CSB-BP510860EJO
CSB-MP510860EJO
CSB-EP510860EJO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Edwardsiella ictaluri NADH-quinone oxidoreductase subunit H (nuoH), partial CSB-YP510861EJO
CSB-EP510861EJO
CSB-BP510861EJO
CSB-MP510861EJO
CSB-EP510861EJO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Edwardsiella ictaluri Orotate phosphoribosyltransferase (pyrE) CSB-YP510862EJO
CSB-EP510862EJO
CSB-BP510862EJO
CSB-MP510862EJO
CSB-EP510862EJO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Edwardsiella ictaluri Phosphopantetheine adenylyltransferase (coaD) CSB-YP510863EJO
CSB-EP510863EJO
CSB-BP510863EJO
CSB-MP510863EJO
CSB-EP510863EJO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Edwardsiella ictaluri 3-methyl-2-oxobutanoate hydroxymethyltransferase (panB) CSB-YP510864EJO
CSB-EP510864EJO
CSB-BP510864EJO
CSB-MP510864EJO
CSB-EP510864EJO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Edwardsiella ictaluri UPF0229 protein NT01EI_1636 (NT01EI_1636) CSB-YP510865EJO
CSB-EP510865EJO
CSB-BP510865EJO
CSB-MP510865EJO
CSB-EP510865EJO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Edwardsiella ictaluri Tetraacyldisaccharide 4'-kinase (lpxK) CSB-YP510866EJO
CSB-EP510866EJO
CSB-BP510866EJO
CSB-MP510866EJO
CSB-EP510866EJO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Edwardsiella ictaluri Iron--sulfur cluster insertion protein ErpA (erpA) CSB-YP510867EJO
CSB-EP510867EJO
CSB-BP510867EJO
CSB-MP510867EJO
CSB-EP510867EJO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Edwardsiella ictaluri UPF0149 protein NT01EI_3357 (NT01EI_3357) CSB-YP510868EJO
CSB-EP510868EJO
CSB-BP510868EJO
CSB-MP510868EJO
CSB-EP510868EJO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Edwardsiella ictaluri Universal stress protein B (uspB), partial CSB-YP510869EJO1
CSB-EP510869EJO1
CSB-BP510869EJO1
CSB-MP510869EJO1
CSB-EP510869EJO1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Edwardsiella ictaluri Dihydroxy-acid dehydratase (ilvD), partial CSB-YP510870EJO
CSB-EP510870EJO
CSB-BP510870EJO
CSB-MP510870EJO
CSB-EP510870EJO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Edwardsiella ictaluri L-seryl-tRNA (Sec) selenium transferase CSB-YP510871EJO
CSB-EP510871EJO
CSB-BP510871EJO
CSB-MP510871EJO
CSB-EP510871EJO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>